Characterization of the organic component of low-molecular-weight chromium-binding substance and its binding of chromium

Journal of Nutrition

Volumn 141, Issue 7, 2011, Pages 1225-1232

  Chen, Yuan ^a   Watson, Heather M ^a   Gao, Junjie ^a   Sinha, Sarmistha Halder ^a   Cassady, Carolyn J ^a   Vincent, John B ^a  

^a UNIVERSITY OF ALABAMA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMIUM; LOW MOLECULAR WEIGHT CHROMIUM BINDING SUBSTANCE; OLIGOPEPTIDE; SYNTHETIC PEPTIDE; TRIFLUOROACETIC ACID; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; BINDING KINETICS; COLLISIONALLY ACTIVATED DISSOCIATION; CONTROLLED STUDY; ISOTHERM; TANDEM MASS SPECTROMETRY;

AMINO ACID SEQUENCE; ANIMALS; CARRIER PROTEINS; CATTLE; CHROMIUM; DIABETES MELLITUS, TYPE 2; HUMANS; KINETICS; MOLECULAR WEIGHT; OLIGOPEPTIDES; PEPTIDE FRAGMENTS; PROTEIN BINDING; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TANDEM MASS SPECTROMETRY; TRACE ELEMENTS;

BOVINAE;

EID: 79960338053     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.111.139147     Document Type: Article

References (39)

1. Vincent JB, Stearns DM. The bioinorganic chemistry of chromium: essentiality, therapeutic agent, toxin, carcinogen? Chichester: Wiley-Blackwell; In press 011.
2. Yamamoto A, Wada O, Ono T. A low-molecular-weight, chromiumbinding substance in mammals. Toxicol Appl Pharmacol. 1981;59: 515-23.
3. Wu GY, Wada O. Studies on a specific chromium binding substance (a low-molecular-weight chromium binding substance) in urine. Sangyo Igaku. 981;23:505-12.
4. Yamamoto A, Wada O, Ono T. Distribution and chromium-binding capacity of a low-molecular-weight, chromium-binding substance in mice. J Inorg Biochem. 1984;22:91-102.
5. Wada O, Manabe S, Yamaguchi N, Ishikawa S, Yanagisawa H. Lowmolecular-weight, chromium-binding substance in rat lungs and its possible role in chromium movement. Ind Health. 1983;21:35-41.
6. Yamamoto A, Wada O, Manabe S. Evidence that chromium is an essential factor for biological activity of low-molecular-weight Cr-binding substance. Biochem Biophys Res Commun. 1989;163:189-93.
7. Yamamoto A, Wada O, Suzuki H. Purification and properties of biologically active chromium complex from bovine colostrum. J Nutr. 1988;118:39-45.
8. Yamamoto A, Wada O, Suzuki H. Separation of biologically active chromium complex from cow colostrum. Tohoku J Exp Med. 1987; 152:211-9.
9. Yamamoto A, Wada O, Ono T. Isolation of a biologically active lowmolecular-mass chromium compound from rabbit liver. Eur J Biochem. 1987;165:627-1.
10. Vincent JB. Relationship between glucose tolerance factor and lowmolecular-weight chromium-binding substance. J Nutr. 1994;124: 117-8.
11. Vincent JB. The biochemistry of chromium. J Nutr. 2000;130:715-8.
12. Davis CM, Vincent JB. Isolation and characterization of a biologically active form of chromium oligopeptide from bovine liver. Arch Biochem Biophys. 997;339:335-43.
13. Sumrall KH, Vincent JB. Is glucose tolerance factor an artifact produced by acid hydrolysis of low-molecular-weight chromium-binding substance? Polyhedron. 1997;16:4171-7.
14. Hatfield MJ, Gillespie S, Chen Y, Li Z, Cassady C, Vincent JB. Lowmolecular-weight chromium-binding substance from chicken liver and American alligator liver. Comp Biochem Physiol B Biochem Mol Biol. 2006;144:423-31.
15. Chen Y. Low-molecular-weight chromium-binding substance: advanced studies from aves to human [dissertation]. Tuscaloosa (AL): The University of labama; 2009.
16. Chan WC, White PD. Fmoc Solid Phase Peptide Synthesis: a practical approach. New York: Oxford University Press; 2000. p. 345.
17. Clipston NL, Jai-nhuknan J, Cassady CJ. A comparison of negative and positive ion time-of-flight post-source decay mass spectrometry for peptides containing basic residues. Int J Mass Spectrom. 2003; 222:363-81.
18. Larsen MR, Cordwell SJ, Roepstorff P. Graphite powder as an alternate or supplement to reverse-phase material for desalting and concentration of peptide mixtures prior to matrix-assisted laser desorption/ionizationmass spectrometry. Proteomics. 2002;2:1277-87.
19. Roepstorff P, Fohlman J. Proposal for a common nomenclature for sequence ions in mass spectra of peptides. Biomed Mass Spectrom. 1984;11:601.
20. Sekiya S, Yamaguchi Y, Kato K, Tanaka K. Mechanistic elucidation of the formation of reduced 2-aminopyridine-derivatized oligosaccharides and their application in matrix-assisted laser desorption/ionization mass spectrometry. Rapid Commun Mass Spectrom. 2005;19:3607-11.
21. Yamaguchi M, Oka M, Nishida K, Ishida M, Hamazaki A, Kuyama H, Ando E, Okamura T-a, Ueyama N, et al. Enhancement of MALDIMS spectra of C-terminal peptides by modification of proteins via an active ester generated in situ from an oxazolone. Anal Chem. 2006; 78:7861-9.
22. Bonfiglio R, King RC, Olah TV, Merkle K. Effects of sample preparation methods on the variability of electrospray ionization response for model drug compounds. Rapid Commun Mass Spectrom. 1999;13: 1175-85.
23. db obese diabetic mice with niacin-bound chromium. Physiol Genomics. 2006;27:370-9.
24. Cheng RYS, Alvord WG, Powell D, Kasprzak KS, Anderson LM. Microarray analysis of altered gene expression in the TM4 Sertoli-likecell line exposed to chromium(III) chloride. Reprod Toxicol. 2002;16: 223-36.
25. Dinakarpandian D, Morrissette V, Chaudhary S, Amini K, Bennett B, Van Horn JD. An informatics search for the low-molecular weight chromium-binding peptide. BMC Chem Biol. 2004;4:2.
26. Aksoyoglu S. Cesium sorption on mylonite. J Radioanal Nucl Chem. 1990;140:301-13.
27. Davis CM, Vincent JB. Chromium oligopeptide activates insulin receptor tyrosine kinase activity. Biochemistry. 1997;36:4382-5.
28. Davis CM, Sumrall KH, Vincent JB. The biologically active form of chromium may activate a membrane phosphotyrosine phopshatase (PTP). Biochemistry. 1996;35:12963-9.
29. Cornish-Bowden A. Principles of enzyme kinetics. London: Buterworths; 1976.
30. 3 to LMWCr. J Biol Inorg Chem. 2000;5:129-36.
31. 2+-activation of striated muscle contraction. Biophys J. 1984;46:541-3.
32. Vincent JB. Chromium: celebrating 50 years as an essential element? Dalton Trans. 2010;39:3878-94.
33. Vincent JB, Stallings D. Introduction: a history of chromium studies (1955-1995). In: Vincent J, editor. The nutritional biochemistry of chromium(III). Amsterdam: Elsevier; 2007. p. 1-40.
34. Vincent JB. The bioinorganic chemistry of chromium(III). Polyhedron. 2001;20:1-26.
35. Di Bona KR, Love S, Rhodes NR, McAdory D, Sinha SH, Kern N, Kent J, Strickland J, Wilson A, et al. Vincent. Chromium is not an essential trace element for mammals: effects of a "low-chromium" diet. J Biol Inorg Chem. 2011;16:381-90.
36. Levina A, Codd R, Dillion CT, Lay PA. Chromium in biology: toxicology and nutritional aspects. Prog Inorg Chem. 2003;51:145-644.
37. Jacquamet L, Sun Y, Hatfield J, Gu W, Cramer SP, Crowder MW, Lorigan GA, Vincent JB, Latour J-M. Characterization of chromodulin by X-ray absorption and electron paramagnetic spectroscopies and magnetic susceptibility measurements. J Am Chem Soc. 2003;125:774-80.
38. Pu D, Vincent J, Cassady C. The effects of chromium(III) coordination on the dissociation of peptides. J Mass Spectrom. 2008;43:773-81.
39. 2O. Polyhedron. 2002;21:155-65.